APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI in Pathology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI in Pathology Market Analysis and Forecast 2026-2032

2 May 2026192 pages

Choose your research edition.

Industry ResearchAI in Pathology Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI in Pathology Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI in Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI in Pathology Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal AI in Pathology Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global AI in Pathology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI in Pathology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI in Pathology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI in Pathology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI in Pathology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI in Pathology include Koninklijke Philips N.V., F.Hoffmann-La Roche Ltd., Hologic, Inc., Visiopharm A/S, Paige AI, Inc., PathAI, Inc., Aiforia Technologies Plc, Indica Labs, Inc. and Optrascan, Inc. (Optra Ventures, LLC), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI in Pathology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI in Pathology, also provides the revenue of main regions and countries. Of the upcoming market potential for AI in Pathology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI in Pathology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI in Pathology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI in Pathology revenue, projected growth trends, production technology, application and end-user industry.

AI in Pathology Segment by Company

Koninklijke Philips N.V.

F.Hoffmann-La Roche Ltd.

Hologic, Inc.

Visiopharm A/S

Paige AI, Inc.

PathAI, Inc.

Aiforia Technologies Plc

Indica Labs, Inc.

Optrascan, Inc. (Optra Ventures, LLC)

MindPeak GmbH

AI in Pathology Segment by Type

Convolutional neural networks (CNNs)

Generative adversarial networks (GANs)

Recurrent neural networks (RNNs)

Others

AI in Pathology Segment by Application

Pharmaceutical & Biotechnology Companies

Hospitals & Reference Laboratories

Academic & Research Institutes

AI in Pathology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI in Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Pathology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI in Pathology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI in Pathology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI in Pathology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI in Pathology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Convolutional neural networks (CNNs) Major Player Table 3. Generative adversarial networks (GANs) Major Player Table 4. Recurrent neural networks (RNNs) Major Player Table 5. Others Major Player Table 6. Global AI in Pathology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical & Biotechnology Companies Major Player Table 8. Hospitals & Reference Laboratories Major Player Table 9. Academic & Research Institutes Major Player Table 10. AI in Pathology Industry Trends Table 11. AI in Pathology Industry Drivers Table 12. AI in Pathology Industry Opportunities and Challenges Table 13. AI in Pathology Industry Restraints Table 14. Global AI in Pathology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global AI in Pathology Market Size by Region (2021-2026) & (US$ Million) Table 16. Global AI in Pathology Market Share by Region (2021-2026) Table 17. Global AI in Pathology Market Size by Region (2027-2032) & (US$ Million) Table 18. Global AI in Pathology Market Share by Region (2027-2032) Table 19. Global AI in Pathology Revenue by Players (US$ Million) & (2021-2026) Table 20. Global AI in Pathology Revenue Market Share by Players (2021-2026) Table 21. Global AI in Pathology Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global AI in Pathology Key Players Headquarters & Area Served Table 23. Global AI in Pathology Players, Product Type & Application Table 24. Global AI in Pathology Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global AI in Pathology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global AI in Pathology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI in Pathology Revenue by Type (2021-2026) & (US$ Million) Table 29. Global AI in Pathology Revenue by Type (2027-2032) & (US$ Million) Table 30. Global AI in Pathology Revenue Market Share by Type (2021-2026) Table 31. Global AI in Pathology Revenue Market Share by Type (2027-2032) Table 32. Global AI in Pathology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI in Pathology Revenue by Application (2021-2026) & (US$ Million) Table 34. Global AI in Pathology Revenue by Application (2027-2032) & (US$ Million) Table 35. Global AI in Pathology Revenue Market Share by Application (2021-2026) Table 36. Global AI in Pathology Revenue Market Share by Application (2027-2032) Table 37. Koninklijke Philips N.V. Company Information Table 38. Koninklijke Philips N.V. Business Overview Table 39. Koninklijke Philips N.V. AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Koninklijke Philips N.V. AI in Pathology Product Portfolio Table 41. Koninklijke Philips N.V. Recent Development Table 42. F.Hoffmann-La Roche Ltd. Company Information Table 43. F.Hoffmann-La Roche Ltd. Business Overview Table 44. F.Hoffmann-La Roche Ltd. AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. F.Hoffmann-La Roche Ltd. AI in Pathology Product Portfolio Table 46. F.Hoffmann-La Roche Ltd. Recent Development Table 47. Hologic, Inc. Company Information Table 48. Hologic, Inc. Business Overview Table 49. Hologic, Inc. AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Hologic, Inc. AI in Pathology Product Portfolio Table 51. Hologic, Inc. Recent Development Table 52. Visiopharm A/S Company Information Table 53. Visiopharm A/S Business Overview Table 54. Visiopharm A/S AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Visiopharm A/S AI in Pathology Product Portfolio Table 56. Visiopharm A/S Recent Development Table 57. Paige AI, Inc. Company Information Table 58. Paige AI, Inc. Business Overview Table 59. Paige AI, Inc. AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Paige AI, Inc. AI in Pathology Product Portfolio Table 61. Paige AI, Inc. Recent Development Table 62. PathAI, Inc. Company Information Table 63. PathAI, Inc. Business Overview Table 64. PathAI, Inc. AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. PathAI, Inc. AI in Pathology Product Portfolio Table 66. PathAI, Inc. Recent Development Table 67. Aiforia Technologies Plc Company Information Table 68. Aiforia Technologies Plc Business Overview Table 69. Aiforia Technologies Plc AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Aiforia Technologies Plc AI in Pathology Product Portfolio Table 71. Aiforia Technologies Plc Recent Development Table 72. Indica Labs, Inc. Company Information Table 73. Indica Labs, Inc. Business Overview Table 74. Indica Labs, Inc. AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Indica Labs, Inc. AI in Pathology Product Portfolio Table 76. Indica Labs, Inc. Recent Development Table 77. Optrascan, Inc. (Optra Ventures, LLC) Company Information Table 78. Optrascan, Inc. (Optra Ventures, LLC) Business Overview Table 79. Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Product Portfolio Table 81. Optrascan, Inc. (Optra Ventures, LLC) Recent Development Table 82. MindPeak GmbH Company Information Table 83. MindPeak GmbH Business Overview Table 84. MindPeak GmbH AI in Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. MindPeak GmbH AI in Pathology Product Portfolio Table 86. MindPeak GmbH Recent Development Table 87. North America AI in Pathology Revenue by Type (2021-2026) & (US$ Million) Table 88. North America AI in Pathology Revenue by Type (2027-2032) & (US$ Million) Table 89. North America AI in Pathology Revenue by Application (2021-2026) & (US$ Million) Table 90. North America AI in Pathology Revenue by Application (2027-2032) & (US$ Million) Table 91. North America AI in Pathology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America AI in Pathology Revenue by Country (2021-2026) & (US$ Million) Table 93. North America AI in Pathology Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe AI in Pathology Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe AI in Pathology Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe AI in Pathology Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe AI in Pathology Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe AI in Pathology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe AI in Pathology Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe AI in Pathology Revenue by Country (US$ Million) & (2027-2032) Table 101. China AI in Pathology Revenue by Type (2021-2026) & (US$ Million) Table 102. China AI in Pathology Revenue by Type (2027-2032) & (US$ Million) Table 103. China AI in Pathology Revenue by Application (2021-2026) & (US$ Million) Table 104. China AI in Pathology Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia AI in Pathology Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia AI in Pathology Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia AI in Pathology Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia AI in Pathology Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia AI in Pathology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia AI in Pathology Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia AI in Pathology Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA AI in Pathology Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA AI in Pathology Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA AI in Pathology Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA AI in Pathology Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA AI in Pathology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA AI in Pathology Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA AI in Pathology Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. AI in Pathology Image Figure 2. Global AI in Pathology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI in Pathology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Convolutional neural networks (CNNs) Image Figure 5. Generative adversarial networks (GANs) Image Figure 6. Recurrent neural networks (RNNs) Image Figure 7. Others Image Figure 8. Global AI in Pathology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global AI in Pathology Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical & Biotechnology Companies Image Figure 11. Hospitals & Reference Laboratories Image Figure 12. Academic & Research Institutes Image Figure 13. Global AI in Pathology Market Size (US$ Million) & (2021-2032) Figure 14. Global AI in Pathology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global AI in Pathology Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global AI in Pathology Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI in Pathology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI in Pathology Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global AI in Pathology Revenue Market Share by Type (2021-2032) Figure 21. Global AI in Pathology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI in Pathology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global AI in Pathology Revenue Market Share by Application (2021-2032) Figure 24. North America AI in Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America AI in Pathology Revenue Share by Type (2021-2032) Figure 26. North America AI in Pathology Revenue Share by Application (2021-2032) Figure 27. North America AI in Pathology Revenue Share by Country (2021-2032) Figure 28. United States AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe AI in Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe AI in Pathology Revenue Share by Type (2021-2032) Figure 33. Europe AI in Pathology Revenue Share by Application (2021-2032) Figure 34. Europe AI in Pathology Revenue Share by Country (2021-2032) Figure 35. Germany AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China AI in Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China AI in Pathology Revenue Share by Type (2021-2032) Figure 45. China AI in Pathology Revenue Share by Application (2021-2032) Figure 46. Asia AI in Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia AI in Pathology Revenue Share by Type (2021-2032) Figure 48. Asia AI in Pathology Revenue Share by Application (2021-2032) Figure 49. Asia AI in Pathology Revenue Share by Region (2021-2032) Figure 50. Japan AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA AI in Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA AI in Pathology Revenue Share by Type (2021-2032) Figure 58. SAMEA AI in Pathology Revenue Share by Application (2021-2032) Figure 59. SAMEA AI in Pathology Revenue Share by Country (2021-2032) Figure 60. Brazil AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt AI in Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Convolutional neural networks (CNNs)
  • Generative adversarial networks (GANs)
  • Recurrent neural networks (RNNs)
  • Others
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Reference Laboratories
  • Academic & Research Institutes
Companies covered
  • Koninklijke Philips N.V.
  • F.Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Visiopharm A/S
  • Paige AI, Inc.
  • PathAI, Inc.
  • Aiforia Technologies Plc
  • Indica Labs, Inc.
  • Optrascan, Inc. (Optra Ventures, LLC)
  • MindPeak GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI in Pathology Market by Type
  3. 1.2.1 Global AI in Pathology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Convolutional neural networks (CNNs)
  5. 1.2.3 Generative adversarial networks (GANs)
  6. 1.2.4 Recurrent neural networks (RNNs)
  7. 1.2.5 Others
  8. 1.3 AI in Pathology Market by Application
  9. 1.3.1 Global AI in Pathology Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical & Biotechnology Companies
  11. 1.3.3 Hospitals & Reference Laboratories
  12. 1.3.4 Academic & Research Institutes
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 AI in Pathology Market Dynamics
  1. 2.1 AI in Pathology Industry Trends
  2. 2.2 AI in Pathology Industry Drivers
  3. 2.3 AI in Pathology Industry Opportunities and Challenges
  4. 2.4 AI in Pathology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI in Pathology Market Perspective (2021-2032)
  2. 3.2 Global AI in Pathology Growth Trends by Region
  3. 3.2.1 Global AI in Pathology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI in Pathology Market Size by Region (2021-2026)
  5. 3.2.3 Global AI in Pathology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI in Pathology Revenue by Players
  2. 4.1.1 Global AI in Pathology Revenue by Players (2021-2026)
  3. 4.1.2 Global AI in Pathology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI in Pathology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI in Pathology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI in Pathology Key Players Headquarters & Area Served
  7. 4.4 Global AI in Pathology Players, Product Type & Application
  8. 4.5 Global AI in Pathology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI in Pathology Market CR5 and HHI
  11. 4.6.3 2025 AI in Pathology Tier 1, Tier 2, and Tier 3
5 AI in Pathology Market Size by Type
  1. 5.1 Global AI in Pathology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI in Pathology Revenue by Type (2021-2032)
  3. 5.3 Global AI in Pathology Revenue Market Share by Type (2021-2032)
6 AI in Pathology Market Size by Application
  1. 6.1 Global AI in Pathology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI in Pathology Revenue by Application (2021-2032)
  3. 6.3 Global AI in Pathology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Koninklijke Philips N.V.
  2. 7.1.1 Koninklijke Philips N.V. Company Information
  3. 7.1.2 Koninklijke Philips N.V. Business Overview
  4. 7.1.3 Koninklijke Philips N.V. AI in Pathology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Koninklijke Philips N.V. AI in Pathology Product Portfolio
  6. 7.1.5 Koninklijke Philips N.V. Recent Developments
  7. 7.2 F.Hoffmann-La Roche Ltd.
  8. 7.2.1 F.Hoffmann-La Roche Ltd. Company Information
  9. 7.2.2 F.Hoffmann-La Roche Ltd. Business Overview
  10. 7.2.3 F.Hoffmann-La Roche Ltd. AI in Pathology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 F.Hoffmann-La Roche Ltd. AI in Pathology Product Portfolio
  12. 7.2.5 F.Hoffmann-La Roche Ltd. Recent Developments
  13. 7.3 Hologic, Inc.
  14. 7.3.1 Hologic, Inc. Company Information
  15. 7.3.2 Hologic, Inc. Business Overview
  16. 7.3.3 Hologic, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hologic, Inc. AI in Pathology Product Portfolio
  18. 7.3.5 Hologic, Inc. Recent Developments
  19. 7.4 Visiopharm A/S
  20. 7.4.1 Visiopharm A/S Company Information
  21. 7.4.2 Visiopharm A/S Business Overview
  22. 7.4.3 Visiopharm A/S AI in Pathology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Visiopharm A/S AI in Pathology Product Portfolio
  24. 7.4.5 Visiopharm A/S Recent Developments
  25. 7.5 Paige AI, Inc.
  26. 7.5.1 Paige AI, Inc. Company Information
  27. 7.5.2 Paige AI, Inc. Business Overview
  28. 7.5.3 Paige AI, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Paige AI, Inc. AI in Pathology Product Portfolio
  30. 7.5.5 Paige AI, Inc. Recent Developments
  31. 7.6 PathAI, Inc.
  32. 7.6.1 PathAI, Inc. Company Information
  33. 7.6.2 PathAI, Inc. Business Overview
  34. 7.6.3 PathAI, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PathAI, Inc. AI in Pathology Product Portfolio
  36. 7.6.5 PathAI, Inc. Recent Developments
  37. 7.7 Aiforia Technologies Plc
  38. 7.7.1 Aiforia Technologies Plc Company Information
  39. 7.7.2 Aiforia Technologies Plc Business Overview
  40. 7.7.3 Aiforia Technologies Plc AI in Pathology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Aiforia Technologies Plc AI in Pathology Product Portfolio
  42. 7.7.5 Aiforia Technologies Plc Recent Developments
  43. 7.8 Indica Labs, Inc.
  44. 7.8.1 Indica Labs, Inc. Company Information
  45. 7.8.2 Indica Labs, Inc. Business Overview
  46. 7.8.3 Indica Labs, Inc. AI in Pathology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Indica Labs, Inc. AI in Pathology Product Portfolio
  48. 7.8.5 Indica Labs, Inc. Recent Developments
  49. 7.9 Optrascan, Inc. (Optra Ventures, LLC)
  50. 7.9.1 Optrascan, Inc. (Optra Ventures, LLC) Company Information
  51. 7.9.2 Optrascan, Inc. (Optra Ventures, LLC) Business Overview
  52. 7.9.3 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Product Portfolio
  54. 7.9.5 Optrascan, Inc. (Optra Ventures, LLC) Recent Developments
  55. 7.10 MindPeak GmbH
  56. 7.10.1 MindPeak GmbH Company Information
  57. 7.10.2 MindPeak GmbH Business Overview
  58. 7.10.3 MindPeak GmbH AI in Pathology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MindPeak GmbH AI in Pathology Product Portfolio
  60. 7.10.5 MindPeak GmbH Recent Developments
8 North America
  1. 8.1 North America AI in Pathology Revenue (2021-2032)
  2. 8.2 North America AI in Pathology Revenue by Type (2021-2032)
  3. 8.2.1 North America AI in Pathology Revenue by Type (2021-2026)
  4. 8.2.2 North America AI in Pathology Revenue by Type (2027-2032)
  5. 8.3 North America AI in Pathology Revenue Share by Type (2021-2032)
  6. 8.4 North America AI in Pathology Revenue by Application (2021-2032)
  7. 8.4.1 North America AI in Pathology Revenue by Application (2021-2026)
  8. 8.4.2 North America AI in Pathology Revenue by Application (2027-2032)
  9. 8.5 North America AI in Pathology Revenue Share by Application (2021-2032)
  10. 8.6 North America AI in Pathology Revenue by Country
  11. 8.6.1 North America AI in Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI in Pathology Revenue by Country (2021-2026)
  13. 8.6.3 North America AI in Pathology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI in Pathology Revenue (2021-2032)
  2. 9.2 Europe AI in Pathology Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI in Pathology Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI in Pathology Revenue by Type (2027-2032)
  5. 9.3 Europe AI in Pathology Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI in Pathology Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI in Pathology Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI in Pathology Revenue by Application (2027-2032)
  9. 9.5 Europe AI in Pathology Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI in Pathology Revenue by Country
  11. 9.6.1 Europe AI in Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI in Pathology Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI in Pathology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI in Pathology Revenue (2021-2032)
  2. 10.2 China AI in Pathology Revenue by Type (2021-2032)
  3. 10.2.1 China AI in Pathology Revenue by Type (2021-2026)
  4. 10.2.2 China AI in Pathology Revenue by Type (2027-2032)
  5. 10.3 China AI in Pathology Revenue Share by Type (2021-2032)
  6. 10.4 China AI in Pathology Revenue by Application (2021-2032)
  7. 10.4.1 China AI in Pathology Revenue by Application (2021-2026)
  8. 10.4.2 China AI in Pathology Revenue by Application (2027-2032)
  9. 10.5 China AI in Pathology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI in Pathology Revenue (2021-2032)
  2. 11.2 Asia AI in Pathology Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI in Pathology Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI in Pathology Revenue by Type (2027-2032)
  5. 11.3 Asia AI in Pathology Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI in Pathology Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI in Pathology Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI in Pathology Revenue by Application (2027-2032)
  9. 11.5 Asia AI in Pathology Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI in Pathology Revenue by Country
  11. 11.6.1 Asia AI in Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI in Pathology Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI in Pathology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI in Pathology Revenue (2021-2032)
  2. 12.2 SAMEA AI in Pathology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI in Pathology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI in Pathology Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI in Pathology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI in Pathology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI in Pathology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI in Pathology Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI in Pathology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI in Pathology Revenue by Country
  11. 12.6.1 SAMEA AI in Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI in Pathology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI in Pathology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst